1 / 45

Neuropathophysiology Synaptic Transmission & Neurotransmitters

Neuropathophysiology Synaptic Transmission & Neurotransmitters . September 24, 2012 Ashkan Afshin. Review Sessions. Format: Questions from last review session (5 min) Questions from last lecture (10 min) Brief review of last lecture (15 min). Epigenetics & Mutation. Epigenetics

robbin
Download Presentation

Neuropathophysiology Synaptic Transmission & Neurotransmitters

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Neuropathophysiology Synaptic Transmission & Neurotransmitters September 24, 2012 Ashkan Afshin

  2. Review Sessions • Format: • Questions from last review session (5 min) • Questions from last lecture (10 min) • Brief review of last lecture (15 min)

  3. Epigenetics & Mutation • Epigenetics Changes in gene expression or cellular phenotype caused by mechanisms other than changes in the underlying DNA sequence (Epi: over, above, outer) • Mutations Accidental changes in a genomic sequence of DNA

  4. Actions of the Serotonin

  5. Serotonin & Norepinephrine A B C

  6. Dopamine A

  7. Chemical Synapses • Allow for one-way transmission of nerve signals. • Are a site of integration of inhibitory and excitatory input. • Are accessible to drugs and toxins.

  8. Synaptic Transmission

  9. Neurotransmitters • Synthesized in the presynaptic neuron • Localized to vesicles in the presynaptic neuron • Released from the presynaptic neuron under physiological conditions • Rabidly removed from the synaptic cleft by uptake or degradation • Presence of receptor on the post-synaptic neuron. • Binding to the receptor elicits a biological response

  10. Neurotransmitters • Norepinephrine (NE) • Serotonin (5-HT) • Dopamine (DA) • Acetylcholine (ACh)

  11. Neurotransmitters • Norepinephrine (NE) • Serotonin (5-HT) • Dopamine (DA) • Appetite • Parkinson's Disease • Depression • Anxiety • Schizophrenia • Addiction

  12. Neurotransmitters • Norepinephrine (NE): mood (↑Anxiety, ↓Depression); appetite • Serotonin (5-HT): mood, appetite, sleep, ↓ Anxiety, Depression  • Dopamine (DA) : movement; behavior; mood; perception ↑Schizophrenia, ↓Parkinson's Disease and Depression  • Acetylcholine (ACh): wakefulness, cognition (memory and learning) - ↓ Alzheimer's Disease, Huntington's Disease, REM Sleep 

  13. Serotonin

  14. Norepinephrine

  15. Monoamine Theory • Depressionis linked to low levels of norepinephrine and/or serotonin. • Maniais linked to high levels of norepinephrine and/or serotonin. • Bipolar mood disorder is alternating cycles of depression and mania.

  16. Treatment of Depression • Drugs that increase the level of norepinephrine and serotonin are used in the treatment of depression. • Major antidepressant drug classes: • Serotonin reuptake inhibitors (SSRIs) • Atypical SSRIs • Tricyclic antidepressants (TCAs) • Monoamine oxidase inhibitors (MAOIs)

  17. Selective Serotonin Reuptake Inhibitors • SSRIs block the reuptake of serotonin back into the serotonergic nerve endings. • This increases the serotonin available to work on the system. • SSRIs are the preferred treatment for major depression and effective for PTSD and OCD.

  18. Selective Serotonin Reuptake Inhibitors • Adverse effects: • GI disturbances • Dry mouth • Sexual dysfunction • Headache • Nervousness • Insomnia • Tremors • Decrease appetite • Weight gain

  19. Selective Serotonin Reuptake Inhibitors

  20. Atypical SSRIs • They block reuptake of serotonin and act on other neurotransmitters and receptors as well. (NE and/or Dopamine) • Like the SSRIs, they have little effect in blocking cholinergic, adrenergic, or histamine receptors.

  21. Atypical SSRIs

  22. MAO Inhibitors

  23. Monoamine Oxidase • Monoamine oxidase (MAO) is an enzyme found in adrenergic and serotonergic nerve endings. • Normal function of MAO is to break down norepinephrine and serotonin. • In mental depression, there appears to be a decrease in the levels of brain norepinephrine and serotonin.

  24. Monoamine Oxidase Inhibitors • By inhibiting MAO, these drugs decrease the amounts of NE and serotonin that are decreased. • Consequently, the MAO inhibitors permit the levels of NE and serotonin in the brain to increase. • They have many drug interactions; caution must be exercised with use of other drugs.

  25. Monoamine Oxidase Inhibitor • Disadvantages of MOAIs: • Dietary restrictions—tyramine • Wine, beer, herring, certain cheeses • Adverse effects: • Dry mouth, urinary retention, constipation, blurred vision, hypotension, weight gain, sexual dysfunction, liver damage that may be fatal • CNS: restlessness, dizziness, insomnia, tremors, seizures, (intensified with over dosage)

  26. Monoamine Oxidase Inhibitor • Tyramine contained in several food items needs MAO-A for it's break down. If the patient is taking MAO inhibitor then there will be great risk of Hypertensive Crisis.Foods should be avoided: • Aged Cheese and most strong tasting cheeses such as cheddar , but cottage cheese is OK • Dark beer and Wines • Processed foods • Overripe Fruits, specially Avocados • Smoked and processed meat and chicken • Chocolate, does not contain Tyramine but it does potentiate MAOI effects

  27. Monoamine Oxidase Inhibitor

  28. Depression Treatment • Monoamine oxidase inhibitors (MAOIs) – block the enzyme that breaks down norepinephrine and serotonin • Selective serotonin reuptake inhibitors (SSRIs) – block reuptake of serotonin by the presynaptic neuron. Eg: Prozac • Serotonin-Norepinephrine reuptake inhibitors – block reuptake of both serotonin and norepinephrine. Some also block dopamine reuptake. Eg: Wellbutrin

  29. However, the monoamine hypothesis is not sufficient to explain major depression • Antidepressant drugs are effective in less than 50% of cases of depression. • Antidepressants must be used for several weeks before their effects are seen – this suggests a more complex interaction between the drug and the nervous system. • Antidepressants and mood stabilizing drugs have wide-spread side effects, suggesting their actions go beyond simply adjusting levels of monoamines.

  30. Genetic polymorphisms may explain why some people are more prone to depression than others. • Eg: there are two forms of the gene for the serotonin transporter. People with the short form of the gene are more likely to experience depression after a major life stress (eg: job loss, divorce, etc). • Similarly, children who have experienced abuse or neglect are more likely to become depressed if they have the short version of the gene.

  31. Stress-induced alterations to the brain may contribute to depression. • The stress response triggers release of hormones that affect certain brain regions, including the hippocampus (short-term memory) and the amygdala (fear). • In experimental animals, stress can lead to changes in the hippocampus that are similar to what is seen in depression. • The same serotonin gene described above appears to make the amygdala hypersensitive.

  32. Tricyclic Antidepressants • Drugs that block the reuptake of norepinephrine and serotonin back into the neuronal nerve endings • Produce varying degrees of sedation, anticholinergic effects, and alpha-adrenergic blocking effects

  33. Tricyclic Antidepressants

  34. Tricyclic Antidepressants

  35. Psychomotor Stimulants • Include the amphetamines and other closely related drugs • Stimulate the CNS by increasing the activity of norepinephrine and dopamine in the brain (reticular formation) • Used to treat narcolepsy, elevate mood (limited), and increase psychomotor activity

  36. Drugs and Dopamine • All addictions are thought to involve dopamine – it provides the drive to repeat pleasurable behaviors eg: smoking, drinking, shopping, etc. • Some drugs directly alter dopamine neurotransmission • Methamphetamine causes the release of large amounts of dopamine • Cocaine blocks reuptake of dopamine at the synapse

  37. Psychomotor Stimulants • Disadvantages: • Drug tolerance and dependence • Increase activity of sympathetic nervous system • Dry mouth • Rapid heartbeat • Increased blood pressure • Restlessness • Insomnia

  38. Psychomotor Stimulants

  39. Cocaine blocks dopamine reuptake – results in feelings of euphoria http://www.nida.nih.gov/NIDA_Notes/NNVol13N2/brain.gif

  40. Methamphetamine use causes permanent damage to the brain http://www.nida.nih.gov/NIDA_Notes/NNVol15N4/Methamphetamine.html

More Related